FC Core Team 2004 - 2005 Projectf Process Priorities Client-Attorney Priveleged Work Product: Do not copy or distribute Strategy IBCY's Project a Processes Command the science: exposure. analytical. fate. effects. human health and ecological Develop and maintain internal 3M analytical capability - telomers and ECF chemistries Develop strategy for external science with respect to telomers and ECF chemistries Understand TFA risk assessment work Develop and implement a 3M Publication Plan: Research to be published as completed in open scienti?c literature - health research Develop and implement a 3M Publication Plan: Research to be published as completed in open scienti?c literature - environmental. Create a process to track global FC related work outside of 3M (Public universities. government institutes. etc..including literature and funding). Develop process to monitor scienti?c literature for new data with respect to health effects and environmental issues Track developments of biomonitoring by Centers for Disease Control (CDC If necessary. hold workshop for third party spokespersons and include preparation for Science Advisory Panel public meetings - Revisit 3M Scienti?c Advisory Board: De?ne role. if any. of 3M SAB in the EPA PFOA risk assessment and PFOS IRIS processes. Develop strategy to present to EPA SAB on PFOA risk assessment. Include industry team. Reestablish international affairs infrastructure-identify resources. responsibilities and relationships to US Core Team. Track agendas for. be aware of and participate in science and regulatory conferences. Develop strategy to build stronger (International) OUS science representation at the Research Science Level Develop strategy to build stronger (International) OUS science representation at the Science Policy Level Develop and implement a program to understand the toxicology and environmental mechanisms for support of the PFOS. PFOA. Review the adequacy of the epidemiology data and address any gaps. Evaluate PFOA precursors in other products. if any. Review the adequacy of the biomonitoring data and address any gaps. Achieve neutral to positive regulatory agency outcomes: ?ndings and actions Develop an Asian strategy for PFOS regulation. Japan being first. Develop an Asian strategy for PFOA regulation. Japan being first. Develop an EU strategy for PFC-S science policy Develop an EU strategy for PFOA science policy Ensure sound science and appropriate risk management at EU level by staying engaged with UK-DEFRA Risk Reduction Strategy Canada - PFC-S Environmental Assessment: Continue to maintain good relations with Environment Canada through regular contacts and strive to ensure that the ?nal assessment - and any actions based thereon - are accurate and fair. OECD: Continue to monitor OECD for further regulatory developments. United Nations Environmental Programme (UNEP): Continue to monitor UNEP activities for further PFOSfPFOA?related Track Activities of Sweden Chemicals Inspectorate. Ensure sound science and appropriate risk management by staying engaged with Review historical use of IRIS reviews by international. national. state and local authorities. Look at related cases and Monitor (US) federal and state legislative and regulatory activities related to FC's. Biomonitoring bill in CA. etc. Prepare and submit ?nal perfluorooctanyl phase-out summary to EPA when 3M inventories are substantially expired. Establish and strengthen dialogue with EPA's 0RD (Dr. Preuss} and management (C. Auer. S. Johnson) and other parties outside EPA who will be influential in PFOS and PFOA risk assessment processes and other science policy matters affecting FC's. US political strategy: Update the political strategy document and key contacts listing and implement agreed plan. Satisfy C8 regulatory commitments Satisfy 3M letter of Intent commitments Satisfy Dyneon letter of Intent (LOI) commitments Society of Plastics Industry Work successfully with FMG and SPI to complete ECA negotiations and implement LOIIECA commitments. Support Association of Plastics Manufacturers in Europe toxicology and environmental study programs. Set up internal management review for Decatur site monitoring issues. Set up internal management review for Gendorf site monitoring issues. Set up internal management review for Cottage Grove site monitoring issues. Satisfy MOU Process - 3M Site Monitoring - PFOA Antwerp groundwaterfsite assessment: Complete risk assessment. Cottage Grove-Drinking Water Dept. of Health}: Determine monitoring and process control requirements. Complete Sle) Self Disclosure and settlement Phase IV audit. Monitor and prioritize external trends and organizations affecting FC's Monitor and understand future direction (globally) of NGO's and partnerships. Effective communication. Media attention to PFOA Risk AssessmenthAB Review: Work with industry group to take the lead on defense of PFOA and science. Maintain preparedness in order to respond to PFOA media coverage of risk assessment. Maintain talking points for and other US regulatory activities. Maintain 3M Sumitomo talking points for PFOA SAB. Develop a message testing mechanism for talking points - particularly in Europe Maintain talking points: 04 chemistry. Maintain talking points: 8(e) voluntary compliance audit. Maintain talking points: Decatur litigation. Assure FC Enterprise Risk Management organizational health. Conduct a resource review (current and prospective} for ongoing issue management needs. C4 Regulatory and Product Stewardship Strategy Maintain dialogue with EPA and international regulators on 04 chemistry. consent orders at the earliest possible time. Include EPA NTP class study activity. Catalog all current 3M 04 product applications. Process and control plan needed. Review the adequacy of the C4 polymer degradation data and address any gaps. Evaluate scenarios for full commercialization of PFBS (modelling project) Develop a reference dose for 04 to determine if environmentalfbiomonitoring need to be done. Improve review process of all 04 commercialization efforts in 3M. Continue phaseout trajectory (CB Prepare a summary of existing per?uorooctanyl inventories across 3M's business units and establish timetables for consumption or usefemissionfexposure reduction) use of inventories. Review PFOS exposure assessments and related information. Develop strategy about monitoring of possible source areas, based on existing PFOS exposure assessments and modelling.